Survodutide

Buy Survodutide — GLP-1/Glucagon Dual Agonist Research Peptide

Researchers looking to buy Survodutide for laboratory study will find this dual receptor agonist an increasingly investigated compound in the metabolic research category. Survodutide is a synthetic peptide engineered to activate two receptors simultaneously — the GLP-1 receptor and the glucagon receptor. It is one of the dual-agonist compounds in current metabolic research, and has drawn particular research interest for hepatic and liver metabolism research applications alongside its body composition research profile.

Mechanism of Action

Survodutide has been investigated in published research for activity across several biological pathways, including:

• GLP-1 receptor agonism — associated with insulin secretion, satiety signaling, and gastric emptying research
• Glucagon receptor agonism — associated with hepatic glucose output, energy expenditure, and lipid metabolism research
• Hepatic metabolism research — Survodutide has notable research interest in liver metabolism and hepatic lipid research models, an application where the glucagon receptor component is particularly relevant
• Energy expenditure research — the glucagon receptor component is studied for its role in metabolic rate and energy expenditure pathways
• Body composition research — investigations into adipose tissue and body composition pathways in research models

Like other GLP-1/glucagon dual agonists, Survodutide combines incretin pathway activation with glucagon receptor activity. Its research literature has developed a particular emphasis on hepatic and liver metabolism research, making it a compound of specific interest for researchers investigating liver-related metabolic pathways in addition to the broader body composition and glucose research applications shared across the dual-agonist category.

Research Applications

Survodutide is used in research contexts including:

• GLP-1 and glucagon receptor pharmacology research
• Hepatic and liver metabolism research models
• Energy expenditure and metabolic rate research
• Body composition and adipose tissue research models
• Lipid metabolism research
• Comparative dual-agonist research (alongside Mazdutide, Tirzepatide)

Product Specifications

• Compound: Survodutide
• Form: Lyophilized white powder
• Purity: ≥99% (verified by HPLC and mass spectrometry)
• Available sizes: 10mg
• Third-party tested: Certificate of Analysis available on request

Reconstitution & Storage

Lyophilized Survodutide should be stored at -20°C for long-term stability and protected from light. Once reconstituted with bacteriostatic water, the solution should be refrigerated at 2–8°C and used within the timeframe indicated on the product COA. Avoid repeated freeze-thaw cycles, as they can degrade peptide integrity.

Reconstitution ratios depend on the specific research protocol being followed.

Shipping & Handling

All orders are shipped with temperature-controlled packaging to preserve peptide integrity. Domestic orders typically arrive within 2–4 business days. Tracking is provided on every order.

Important Disclaimer

This product is sold strictly for laboratory research and in-vitro use only. It is not intended for human or animal consumption, diagnostic use, therapeutic use, weight management, or any form of clinical or personal application. By purchasing, you confirm that you are a qualified researcher or affiliated with a licensed research institution and that this product will be handled in accordance with all applicable laws and safety standards.

Survodutide is an investigational compound and is not approved by the FDA or any regulatory authority for human use.